Doxil (doxorubicin hydrochloride liposome injection) 50 recall: CGMP Deviations
Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), Single-Dose Vial, Rx only, Manufactured for: Baxter Healthcare…
Why was Doxil (doxorubicin hydrochloride liposome injection) 50 recalled?
CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were released by mistake.
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
Lot# MKZSU02, Exp 6/30/2024
- Product
- Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), Single-Dose Vial, Rx only, Manufactured for: Baxter Healthcare…
- Recalling firm
- Baxter Healthcare Corporation
- Quantity
- 472 vials
- Distribution
- Nationwide in the USA
- Recall date
- October 25, 2023
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)